We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 18.00 | 23.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/7/2017 21:20 | and it did $14.20 (3.05%) | football | |
31/7/2017 15:14 | $14 plus I wonder if it will hold above that? | football | |
28/7/2017 22:01 | Final close on NASDAQ is $13.78 (Todays High) which at current exchange rates is £2.10 hopefully this will further increase next week & pull AIM up further next week. Recent publication per HM above seems to have created further interest.In addition 7,983 was the total numbers & included as last transaction of 1,000 at $13.7674. Momentum is building & it is still the 'Summer' - roll on £2.50 (Ask). | chrisatrdg | |
28/7/2017 15:07 | Their new CEO just bought up $2 million worth of shares as a show of good faith but not sure how the rights issue actually finalised ... I thought it was all taken up? (EDIT - perhaps not all officially reported ... so not certain of that? As I type the SMMT NASDAQ share price making another upward concerted effort north of $13.75) | hugus maximus | |
28/7/2017 14:51 | Sarepta's rights issue (I think they call them secondary issue over there) subscription period ended yesterday. Anyone seen how well that went? Sarepta have been criticised for diluting shareholders yet again. | solomon | |
28/7/2017 13:55 | Yesterday in the USA : Summit Therapeutics PLC Given Consensus Recommendation of “Buy” by Brokerages & $25 average objective : | hugus maximus | |
27/7/2017 17:28 | What a sad day Stany. It sounds as if you will miss him. We all send our condolences. | hugus maximus | |
27/7/2017 16:56 | It's sad that Joe has gone. My commiserations. Hopefully his family will benefit from a good outcome with his SUMM investment. | solomon | |
27/7/2017 16:31 | Very sorry to hear it Stany. | waterloo01 | |
27/7/2017 16:06 | MY FRIEND JOE Died this morning we have been in summ for a few years talking and waiting for summ to come good sods law it appears to be on the rise hope it is but would have loved it for joe to be able to appreciate success | stany6 | |
27/7/2017 15:31 | correct and ive been here years lol | cautiousmoney | |
27/7/2017 15:26 | A reminder - Warren Buffett's catch phrase: | chrisatrdg | |
27/7/2017 15:22 | irrespective of NASDAQ usual AIM no significant buys in fact more sells and the share price rises someone knows something this is going to erupt £3.50 - £6 AIMHO but wheres the right time to exit ??? long term im here for £10+ but ihave some to play with GLA great times ahead | cautiousmoney | |
27/7/2017 13:51 | Think any SRPT takeover more likely to be their paper plus cash sweetener. | wildbunch | |
27/7/2017 12:20 | No its just MMs closing gap between us and nasdaq imo hoping to generate a bit of interest ! And they drew out a 10k buy it seems. | luminoso | |
27/7/2017 10:21 | With no logged buys or sales ... almost an hour into trading and the share price moves up from 197.5 to £2? EDIT @ 11.20 am ... 84 buys and 961 sells, produces one of the largest AIM share price hikes in a while ... is this NASDAQ traders ( yet unpublished trades )buying cheap on AIM? | hugus maximus | |
26/7/2017 21:59 | Final close $13.62 which at todays exchange rate is £2.08 & again is ahead of AIM which is slowly catching up also note there were a large number of transaction today 51,197.Clearly an increase in interest in Summit state side fuelling the notion that SRPT may have their own interest in SMMT. | chrisatrdg | |
26/7/2017 20:17 | $13.89 up 0.89 (6.85%) | football | |
26/7/2017 15:50 | I think others have a similar view to the one expressed re SRPT and the cash. | waterloo01 | |
26/7/2017 15:23 | Great potential again today on NASDAQ ... does anyone have a view about whether this is simply riding on Sarepta's coattails or is this as a result of renewed interest in Summit? (Or perhaps both?) | hugus maximus | |
26/7/2017 11:36 | Glaxo spent $130 million in the second quarter acquiring a priority review voucher to expedite the Food and Drug Administration's assessment. Haven't SUMM got one of those? More than the market cap. | solomon | |
26/7/2017 08:33 | Hugus - I don't think your speech-to-text app is working correctly. | solomon | |
26/7/2017 08:24 | MMs clearly playing a different game with the share price to the world that they allow us to be are privy to. EDIT for Solomon! Whoops. | hugus maximus | |
25/7/2017 23:04 | At current exchange rates NASDAQ close is £2 based on a $13 close hopefully this will be reflected on AIM Wednesday. | chrisatrdg | |
25/7/2017 22:07 | £13 close USA | football |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions